Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens

Infectious diseases are an existential health threat, potentiated by emerging and re-emerging viruses and increasing bacterial antibiotic resistance. Targeted treatment of infectious diseases requires precision diagnostics, especially in cases where broad-range therapeutics such as antibiotics fail....

Full description

Bibliographic Details
Main Authors: Alex van Belkum, Carina Almeida, Benjamin Bardiaux, Sarah V. Barrass, Sarah J. Butcher, Tuğçe Çaykara, Sounak Chowdhury, Rucha Datar, Ian Eastwood, Adrian Goldman, Manisha Goyal, Lotta Happonen, Nadia Izadi-Pruneyre, Theis Jacobsen, Pirjo H. Johnson, Volkhard A. J. Kempf, Andreas Kiessling, Juan Leva Bueno, Anchal Malik, Johan Malmström, Ina Meuskens, Paul A. Milner, Michael Nilges, Nicole Pamme, Sally A. Peyman, Ligia R. Rodrigues, Pablo Rodriguez-Mateos, Maria G. Sande, Carla Joana Silva, Aleksandra Cecylia Stasiak, Thilo Stehle, Arno Thibau, Diana J. Vaca, Dirk Linke
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/7/1259
_version_ 1797527301827592192
author Alex van Belkum
Carina Almeida
Benjamin Bardiaux
Sarah V. Barrass
Sarah J. Butcher
Tuğçe Çaykara
Sounak Chowdhury
Rucha Datar
Ian Eastwood
Adrian Goldman
Manisha Goyal
Lotta Happonen
Nadia Izadi-Pruneyre
Theis Jacobsen
Pirjo H. Johnson
Volkhard A. J. Kempf
Andreas Kiessling
Juan Leva Bueno
Anchal Malik
Johan Malmström
Ina Meuskens
Paul A. Milner
Michael Nilges
Nicole Pamme
Sally A. Peyman
Ligia R. Rodrigues
Pablo Rodriguez-Mateos
Maria G. Sande
Carla Joana Silva
Aleksandra Cecylia Stasiak
Thilo Stehle
Arno Thibau
Diana J. Vaca
Dirk Linke
author_facet Alex van Belkum
Carina Almeida
Benjamin Bardiaux
Sarah V. Barrass
Sarah J. Butcher
Tuğçe Çaykara
Sounak Chowdhury
Rucha Datar
Ian Eastwood
Adrian Goldman
Manisha Goyal
Lotta Happonen
Nadia Izadi-Pruneyre
Theis Jacobsen
Pirjo H. Johnson
Volkhard A. J. Kempf
Andreas Kiessling
Juan Leva Bueno
Anchal Malik
Johan Malmström
Ina Meuskens
Paul A. Milner
Michael Nilges
Nicole Pamme
Sally A. Peyman
Ligia R. Rodrigues
Pablo Rodriguez-Mateos
Maria G. Sande
Carla Joana Silva
Aleksandra Cecylia Stasiak
Thilo Stehle
Arno Thibau
Diana J. Vaca
Dirk Linke
author_sort Alex van Belkum
collection DOAJ
description Infectious diseases are an existential health threat, potentiated by emerging and re-emerging viruses and increasing bacterial antibiotic resistance. Targeted treatment of infectious diseases requires precision diagnostics, especially in cases where broad-range therapeutics such as antibiotics fail. There is thus an increasing need for new approaches to develop sensitive and specific in vitro diagnostic (IVD) tests. Basic science and translational research are needed to identify key microbial molecules as diagnostic targets, to identify relevant host counterparts, and to use this knowledge in developing or improving IVD. In this regard, an overlooked feature is the capacity of pathogens to adhere specifically to host cells and tissues. The molecular entities relevant for pathogen–surface interaction are the so-called adhesins. Adhesins vary from protein compounds to (poly-)saccharides or lipid structures that interact with eukaryotic host cell matrix molecules and receptors. Such interactions co-define the specificity and sensitivity of a diagnostic test. Currently, adhesin-receptor binding is typically used in the pre-analytical phase of IVD tests, focusing on pathogen enrichment. Further exploration of adhesin–ligand interaction, supported by present high-throughput “omics” technologies, might stimulate a new generation of broadly applicable pathogen detection and characterization tools. This review describes recent results of novel structure-defining technologies allowing for detailed molecular analysis of adhesins, their receptors and complexes. Since the host ligands evolve slowly, the corresponding adhesin interaction is under selective pressure to maintain a constant receptor binding domain. IVD should exploit such conserved binding sites and, in particular, use the human ligand to enrich the pathogen. We provide an inventory of methods based on adhesion factors and pathogen attachment mechanisms, which can also be of relevance to currently emerging pathogens, including SARS-CoV-2, the causative agent of COVID-19.
first_indexed 2024-03-10T09:42:00Z
format Article
id doaj.art-489cc0016c134be3b318bf59f4b4c4f1
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-10T09:42:00Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-489cc0016c134be3b318bf59f4b4c4f12023-11-22T03:35:09ZengMDPI AGDiagnostics2075-44182021-07-01117125910.3390/diagnostics11071259Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging PathogensAlex van Belkum0Carina Almeida1Benjamin Bardiaux2Sarah V. Barrass3Sarah J. Butcher4Tuğçe Çaykara5Sounak Chowdhury6Rucha Datar7Ian Eastwood8Adrian Goldman9Manisha Goyal10Lotta Happonen11Nadia Izadi-Pruneyre12Theis Jacobsen13Pirjo H. Johnson14Volkhard A. J. Kempf15Andreas Kiessling16Juan Leva Bueno17Anchal Malik18Johan Malmström19Ina Meuskens20Paul A. Milner21Michael Nilges22Nicole Pamme23Sally A. Peyman24Ligia R. Rodrigues25Pablo Rodriguez-Mateos26Maria G. Sande27Carla Joana Silva28Aleksandra Cecylia Stasiak29Thilo Stehle30Arno Thibau31Diana J. Vaca32Dirk Linke33BioMérieux, Open Innovation & Partnerships, 38390 La Balme Les Grottes, FranceBiomode, 4715-330 Braga, PortugalInstitut Pasteur, Structural Biology and Chemistry, 75724 Paris, FranceDepartment of Biological Sciences, University of Helsinki, 00014 Helsinki, FinlandDepartment of Biological Sciences, University of Helsinki, 00014 Helsinki, FinlandCentre for Nanotechnology and Smart Materials, 4760-034 Vila Nova de Famalicão, PortugalDivision of Infection Medicine, Department of Clinical Sciences, Lund University, 22242 Lund, SwedenBioMérieux, Microbiology R&D, 38390 La Balme Les Grottes, FranceEluceda, Burnley BB11 5UB, UKDepartment of Biological Sciences, University of Helsinki, 00014 Helsinki, FinlandBioMérieux, Open Innovation & Partnerships, 38390 La Balme Les Grottes, FranceDivision of Infection Medicine, Department of Clinical Sciences, Lund University, 22242 Lund, SwedenInstitut Pasteur, Structural Biology and Chemistry, 75724 Paris, FranceInstitut Pasteur, Structural Biology and Chemistry, 75724 Paris, FranceSchool of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UKInstitute for Medical Microbiology and Infection Control, University Hospital, Goethe-University, 60596 Frankfurt am Main, GermanySchool of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UKSchool of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UKSchool of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UKDivision of Infection Medicine, Department of Clinical Sciences, Lund University, 22242 Lund, SwedenDepartment of Biosciences, University of Oslo, 0316 Oslo, NorwaySchool of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UKInstitut Pasteur, Structural Biology and Chemistry, 75724 Paris, FranceSchool of Mathematics and Physical Sciences, University of Hull, Hull HU6 7RX, UKSchool of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UKCEB—Centre of Biological Engineering, University of Minho, 4710-057 Braga, PortugalSchool of Mathematics and Physical Sciences, University of Hull, Hull HU6 7RX, UKCEB—Centre of Biological Engineering, University of Minho, 4710-057 Braga, PortugalCentre for Nanotechnology and Smart Materials, 4760-034 Vila Nova de Famalicão, PortugalInterfaculty Institute of Biochemistry, University of Tübingen, 72076 Tübingen, GermanyInterfaculty Institute of Biochemistry, University of Tübingen, 72076 Tübingen, GermanyInstitute for Medical Microbiology and Infection Control, University Hospital, Goethe-University, 60596 Frankfurt am Main, GermanyInstitute for Medical Microbiology and Infection Control, University Hospital, Goethe-University, 60596 Frankfurt am Main, GermanyDepartment of Biosciences, University of Oslo, 0316 Oslo, NorwayInfectious diseases are an existential health threat, potentiated by emerging and re-emerging viruses and increasing bacterial antibiotic resistance. Targeted treatment of infectious diseases requires precision diagnostics, especially in cases where broad-range therapeutics such as antibiotics fail. There is thus an increasing need for new approaches to develop sensitive and specific in vitro diagnostic (IVD) tests. Basic science and translational research are needed to identify key microbial molecules as diagnostic targets, to identify relevant host counterparts, and to use this knowledge in developing or improving IVD. In this regard, an overlooked feature is the capacity of pathogens to adhere specifically to host cells and tissues. The molecular entities relevant for pathogen–surface interaction are the so-called adhesins. Adhesins vary from protein compounds to (poly-)saccharides or lipid structures that interact with eukaryotic host cell matrix molecules and receptors. Such interactions co-define the specificity and sensitivity of a diagnostic test. Currently, adhesin-receptor binding is typically used in the pre-analytical phase of IVD tests, focusing on pathogen enrichment. Further exploration of adhesin–ligand interaction, supported by present high-throughput “omics” technologies, might stimulate a new generation of broadly applicable pathogen detection and characterization tools. This review describes recent results of novel structure-defining technologies allowing for detailed molecular analysis of adhesins, their receptors and complexes. Since the host ligands evolve slowly, the corresponding adhesin interaction is under selective pressure to maintain a constant receptor binding domain. IVD should exploit such conserved binding sites and, in particular, use the human ligand to enrich the pathogen. We provide an inventory of methods based on adhesion factors and pathogen attachment mechanisms, which can also be of relevance to currently emerging pathogens, including SARS-CoV-2, the causative agent of COVID-19.https://www.mdpi.com/2075-4418/11/7/1259adhesinreceptorinfectious diseasesdiagnostics
spellingShingle Alex van Belkum
Carina Almeida
Benjamin Bardiaux
Sarah V. Barrass
Sarah J. Butcher
Tuğçe Çaykara
Sounak Chowdhury
Rucha Datar
Ian Eastwood
Adrian Goldman
Manisha Goyal
Lotta Happonen
Nadia Izadi-Pruneyre
Theis Jacobsen
Pirjo H. Johnson
Volkhard A. J. Kempf
Andreas Kiessling
Juan Leva Bueno
Anchal Malik
Johan Malmström
Ina Meuskens
Paul A. Milner
Michael Nilges
Nicole Pamme
Sally A. Peyman
Ligia R. Rodrigues
Pablo Rodriguez-Mateos
Maria G. Sande
Carla Joana Silva
Aleksandra Cecylia Stasiak
Thilo Stehle
Arno Thibau
Diana J. Vaca
Dirk Linke
Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
Diagnostics
adhesin
receptor
infectious diseases
diagnostics
title Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
title_full Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
title_fullStr Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
title_full_unstemmed Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
title_short Host-Pathogen Adhesion as the Basis of Innovative Diagnostics for Emerging Pathogens
title_sort host pathogen adhesion as the basis of innovative diagnostics for emerging pathogens
topic adhesin
receptor
infectious diseases
diagnostics
url https://www.mdpi.com/2075-4418/11/7/1259
work_keys_str_mv AT alexvanbelkum hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT carinaalmeida hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT benjaminbardiaux hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT sarahvbarrass hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT sarahjbutcher hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT tugcecaykara hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT sounakchowdhury hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT ruchadatar hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT ianeastwood hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT adriangoldman hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT manishagoyal hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT lottahapponen hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT nadiaizadipruneyre hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT theisjacobsen hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT pirjohjohnson hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT volkhardajkempf hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT andreaskiessling hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT juanlevabueno hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT anchalmalik hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT johanmalmstrom hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT inameuskens hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT paulamilner hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT michaelnilges hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT nicolepamme hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT sallyapeyman hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT ligiarrodrigues hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT pablorodriguezmateos hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT mariagsande hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT carlajoanasilva hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT aleksandracecyliastasiak hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT thilostehle hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT arnothibau hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT dianajvaca hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens
AT dirklinke hostpathogenadhesionasthebasisofinnovativediagnosticsforemergingpathogens